These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 35571127)

  • 1. The Histone Deacetylase Inhibitor I1 Induces Differentiation of Acute Leukemia Cells With MLL Gene Rearrangements
    Yao J; Li G; Cui Z; Chen P; Wang J; Hu Z; Zhang L; Wei L
    Front Pharmacol; 2022; 13():876076. PubMed ID: 35571127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Jiyuan Oridonin A Overcomes Differentiation Blockade in Acute Myeloid Leukemia Cells With MLL Rearrangements
    Qu M; Duan Y; Zhao M; Wang Z; Zhao M; Zhao Y; Wang H; Ke Y; Liu Y; Liu HM; Wei L; Hu Z
    Front Oncol; 2021; 11():659720. PubMed ID: 33842376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histone Deacetylase Inhibitor I3 Induces the Differentiation of Acute Myeloid Leukemia Cells with
    Zhao M; Duan Y; Wang J; Liu Y; Zhao Y; Wang H; Zhang L; Chen ZS; Hu Z; Wei L
    J Oncol; 2022; 2022():3345536. PubMed ID: 36072977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Histone Deacetylase Inhibitor I13 Induces Differentiation of M2, M3 and M5 Subtypes of Acute Myeloid Leukemia Cells and Leukemic Stem-Like Cells.
    Ma X; Zhao M; Wu ZX; Yao J; Zhang L; Wang J; Hu Z; Wei L; Chen ZS
    Front Oncol; 2022; 12():855570. PubMed ID: 35494054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentiation of Acute Leukemia Cells Including Cells with MLL-AF4 Rearrangements Induced by Jiyuan Oridonin A.
    Li X; Zhang F; Ke Y; Liu H; Hu Z; Wei L
    Recent Pat Anticancer Drug Discov; 2024 Jan; ():. PubMed ID: 38204268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensitivity of MLL-rearranged AML cells to all-trans retinoic acid is associated with the level of H3K4me2 in the RARα promoter region.
    Sakamoto K; Imamura T; Yano M; Yoshida H; Fujiki A; Hirashima Y; Hosoi H
    Blood Cancer J; 2014 Apr; 4(4):e205. PubMed ID: 24769646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. JMJD1C-regulated lipid synthesis contributes to the maintenance of
    Qi D; Wang J; Zhao Y; Yang Y; Wang Y; Wang H; Wang L; Wang Z; Xu X; Hu Z
    Leuk Lymphoma; 2022 Sep; 63(9):2149-2160. PubMed ID: 35468015
    [No Abstract]   [Full Text] [Related]  

  • 8. Histone Acetyltransferase p300/CREB-binding Protein-associated Factor (PCAF) Is Required for All-
    Sunami Y; Araki M; Kan S; Ito A; Hironaka Y; Imai M; Morishita S; Ohsaka A; Komatsu N
    J Biol Chem; 2017 Feb; 292(7):2815-2829. PubMed ID: 28053092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Co-inhibition of HDAC and MLL-menin interaction targets MLL-rearranged acute myeloid leukemia cells via disruption of DNA damage checkpoint and DNA repair.
    Ye J; Zha J; Shi Y; Li Y; Yuan D; Chen Q; Lin F; Fang Z; Yu Y; Dai Y; Xu B
    Clin Epigenetics; 2019 Oct; 11(1):137. PubMed ID: 31590682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small molecular modulators of JMJD1C preferentially inhibit growth of leukemia cells.
    Xu X; Wang L; Hu L; Dirks WG; Zhao Y; Wei Z; Chen D; Li Z; Wang Z; Han Y; Wei L; Drexler HG; Hu Z
    Int J Cancer; 2020 Jan; 146(2):400-412. PubMed ID: 31271662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of the interplay between all-trans retinoic acid and histone deacetylase inhibitors in leukemic cells.
    Noack K; Mahendrarajah N; Hennig D; Schmidt L; Grebien F; Hildebrand D; Christmann M; Kaina B; Sellmer A; Mahboobi S; Kubatzky K; Heinzel T; Krämer OH
    Arch Toxicol; 2017 May; 91(5):2191-2208. PubMed ID: 27807597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. OGP46 Induces Differentiation of Acute Myeloid Leukemia Cells via Different Optimal Signaling Pathways.
    Zhao M; Wang J; Qu M; Zhao Y; Wang H; Ke Y; Liu Y; Lei ZN; Liu HM; Hu Z; Wei L; Chen ZS
    Front Cell Dev Biol; 2021; 9():652972. PubMed ID: 33748146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Bromodomain Inhibitor JQ1 Enhances the Responses to All-
    Kang C; Kim CY; Kim HS; Park SP; Chung HM
    Int J Stem Cells; 2018 May; 11(1):131-140. PubMed ID: 29699387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Class IIA Histone Deacetylase (HDAC) Inhibitor TMP269 Downregulates Ribosomal Proteins and Has Anti-Proliferative and Pro-Apoptotic Effects on AML Cells.
    Urwanisch L; Unger MS; Sieberer H; Dang HH; Neuper T; Regl C; Vetter J; Schaller S; Winkler SM; Kerschbamer E; Weichenberger CX; Krenn PW; Luciano M; Pleyer L; Greil R; Huber CG; Aberger F; Horejs-Hoeck J
    Cancers (Basel); 2023 Feb; 15(4):. PubMed ID: 36831382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The CDK9 Inhibitor Dinaciclib Exerts Potent Apoptotic and Antitumor Effects in Preclinical Models of MLL-Rearranged Acute Myeloid Leukemia.
    Baker A; Gregory GP; Verbrugge I; Kats L; Hilton JJ; Vidacs E; Lee EM; Lock RB; Zuber J; Shortt J; Johnstone RW
    Cancer Res; 2016 Mar; 76(5):1158-69. PubMed ID: 26627013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time- and residue-specific differences in histone acetylation induced by VPA and SAHA in AML1/ETO-positive leukemia cells.
    Barbetti V; Gozzini A; Cheloni G; Marzi I; Fabiani E; Santini V; Dello Sbarba P; Rovida E
    Epigenetics; 2013 Feb; 8(2):210-9. PubMed ID: 23321683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reprogramming acute myeloid leukemia into sensitivity for retinoic-acid-driven differentiation.
    van Gils N; Verhagen HJMP; Smit L
    Exp Hematol; 2017 Aug; 52():12-23. PubMed ID: 28456748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective DOT1L, LSD1, and HDAC Class I Inhibitors Reduce HOXA9 Expression in MLL-AF9 Rearranged Leukemia Cells, But Dysregulate the Expression of Many Histone-Modifying Enzymes.
    Lillico R; Lawrence CK; Lakowski TM
    J Proteome Res; 2018 Aug; 17(8):2657-2667. PubMed ID: 29972300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrative methylome-transcriptome analysis unravels cancer cell vulnerabilities in infant MLL-rearranged B cell acute lymphoblastic leukemia.
    Tejedor JR; Bueno C; Vinyoles M; Petazzi P; Agraz-Doblas A; Cobo I; Torres-Ruiz R; Bayón GF; Pérez RF; López-Tamargo S; Gutierrez-Agüera F; Santamarina-Ojeda P; Ramírez-Orellana M; Bardini M; Cazzaniga G; Ballerini P; Schneider P; Stam RW; Varela I; Fraga MF; Fernández AF; Menéndez P
    J Clin Invest; 2021 Jul; 131(13):. PubMed ID: 33983906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ZNF521 sustains the differentiation block in MLL-rearranged acute myeloid leukemia.
    Germano G; Morello G; Aveic S; Pinazza M; Minuzzo S; Frasson C; Persano L; Bonvini P; Viola G; Bresolin S; Tregnago C; Paganin M; Pigazzi M; Indraccolo S; Basso G
    Oncotarget; 2017 Apr; 8(16):26129-26141. PubMed ID: 28412727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.